Exciting results today from Sana Bio. Only n=1 and very preliminary, but fantastic to see allogenic (deceased donor) islet efficacy and safety WITHOUT immunosuppression! It will be fantastic to see this applied to stem cell-derived islets.
www.globenewswire.com/news-release...
globenewswire.com
Sana Biotechnology Announces Positive Clinical Results from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression
First-in-Human Study Provides Evidence that Sana’s Hypoimmune (HIP) Technology Enables Transplanted Islet Cells to Avoid Immune Rejection and Produce...